Enveric Biosciences (ENVB) Share-based Compensation (2016 - 2026)
Enveric Biosciences (ENVB) reported Share-based Compensation of $125,114 for Q2 2026, down 39.3% from $206,260 a year earlier but up 41.1% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Share-based Compensation (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enveric Biosciences' Share-based Compensation came in at $641,002, down 48.4% year-over-year; for FY2025, it was $827,323, down 47.0% from FY2024.
- Share-based Compensation has declined for four consecutive years, with a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $1.56 million in FY2024 (-27.3%), $2.15 million in FY2023 (-18.0%), $2.62 million in FY2022 (-79.2%) and $12.6 million in FY2021 (+537.1%).
- Five-year quarterly Share-based Compensation spans a low of $88,673 in Q1 2026 and a high of $7.77 million in Q4 2021.
- Year over year, Share-based Compensation has now declined in each of the last six quarters, with an average decline of 31.6% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q3 2022 (growth of 32.5%); the low point was Q4 2022 (a decline of 93.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $88,673 (Q1 2026), $240,234 (Q4 2025) and $186,981 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - | 125,114.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125,114.00 |
| Mar 31, 2026 | 88,673.00 |
| Dec 31, 2025 | 240,234.00 |
| Sep 30, 2025 | 186,567.00 |
| Jun 30, 2025 | 206,260.00 |
| Mar 31, 2025 | 193,848.00 |
| Dec 31, 2024 | 465,822.00 |
| Sep 30, 2024 | 369,200.00 |
| Jun 30, 2024 | 369,200.00 |
| Mar 31, 2024 | 358,170.00 |
| Dec 31, 2023 | 364,728.00 |
| Sep 30, 2023 | 328,253.00 |
| Jun 30, 2023 | 825,363.00 |
| Mar 31, 2023 | 532,835.00 |
| Dec 31, 2022 | 529,372.00 |
| Sep 30, 2022 | 590,190.00 |
| Jun 30, 2022 | 622,596.00 |
| Mar 31, 2022 | 768,619.00 |
| Dec 31, 2021 | 7.77 Mn |
| Sep 30, 2021 | 434,403.00 |
API Access
Enveric Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();